68308-685 : Tazarotene 1 mg/g Topical Aerosol, Foam


NDC: 68308-685
Labeler: Mayne Pharma Inc.
Product Type: Human Prescription Drug
Drug Name:  Tazarotene
Dosage Form: Topical Aerosol, Foam
Application #: NDA202428
Rev. Date: 


NDC Package Codes:

  • 68308-685-50: 1 CAN IN 1 CARTON (68308‑685‑50) > 50 G IN 1 CAN

Active Ingredients:

  • Tazarotene

Dosage Strength:

  • 1 mg/g

Pharmaceutical Classes:

  • Retinoid [EPC]
  • Retinoids [CS]

Related Products:

Based on records with the same trade name.
  • 68308-745 Tazarotene 1 mg/g Topical Cream by Mayne Pharma
  • 0168-0454 Tazarotene 1 mg/g Topical Cream by Fougera Pharmaceuticals Inc.
  • 0713-0670 Tazarotene 1 mg/g Topical Cream by G&w Laboratories, Inc.
  • 0713-0764 Tazarotene 1 mg/g Topical Cream by Cosette Pharmaceuticals, Inc.
  • 0713-0804 Tazarotene 1 mg/g Topical Gel by Cosette Pharmaceuticals, Inc.
  • 0713-0805 Tazarotene .5 mg/g Topical Gel by Cosette Pharmaceuticals, Inc.
  • 45802-436 Tazarotene .5 mg/g Topical Gel by Padagis Israel Pharmaceuticals Ltd
  • 45802-442 Tazarotene 1 mg/g Topical Gel by Padagis Israel Pharmaceuticals Ltd
  • 51672-1373 Tazarotene 1 mg/g Topical Cream by Taro Pharmaceuticals U.S.a., Inc.
  • 51672-1374 Tazarotene 1 mg/g Topical Cream by Taro Pharmaceuticals U.S.a., Inc.
  • 60758-556 Tazarotene .5 mg/g Topical Cream by Pacific Pharma, Inc.
  • 60758-561 Tazarotene 1 mg/g Topical Cream by Pacific Pharma, Inc.
  • 72162-2202 Tazarotene 1 mg/g Topical Gel by Bryant Ranch Prepack
  • 73473-309 Tazarotene .5 mg/g Cutaneous Gel by Solaris Pharma Corporation
  • 73473-310 Tazarotene 1 mg/g Cutaneous Gel by Solaris Pharma Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68308-685 QR Code

< Prev: 68308-668Next: 68308-701 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.